Gregor Krings, MD, PhD

Title(s)Associate Professor, Pathology
SchoolSchool of Medicine
Address513 Parnassus Avenue, HSW, #450E
San Francisco CA 94143
Phone415-514-0867
vCardDownload vCard

    Collapse Overview 

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior. Mod Pathol. 2023 Feb 06; 36(5):100125. Schwartz CJ, Ruiz J, Bean GR, Sirohi D, Joseph NM, Hosfield EM, Jacobs TW, Mukhtar RA, Chen YY, Krings G. PMID: 36870308.
      View in: PubMed   Mentions:    Fields:    
    2. Less Common Triple-Negative Breast Cancers. . 2022 Nov 24; 463-573. Vohra VP, Chen CY, Krings KG. .
      View in: Publisher Site   Mentions:
    3. Fibroepithelial Lesions. . 2022 Nov 24; 253-330. Krings KG, Chen CY. .
      View in: Publisher Site   Mentions:
    4. Atypical Lobular Hyperplasia and Lobular Carcinoma In Situ. . 2022 Nov 24; 615-654. Krings KG, Hwang HH, Chen CY. .
      View in: Publisher Site   Mentions:
    5. Association of Residual Ductal Carcinoma In Situ With Breast Cancer Recurrence in the Neoadjuvant I-SPY2 Trial. JAMA Surg. 2022 Nov 01; 157(11):1034-1041. Osdoit M, Yau C, Symmans WF, Boughey JC, Ewing CA, Balassanian R, Chen YY, Krings G, Wallace AM, Zare S, Fadare O, Lancaster R, Wei S, Godellas CV, Tang P, Tuttle TM, Klein M, Sahoo S, Hieken TJ, Carter JM, Chen B, Ahrendt G, Tchou J, Feldman M, Tousimis E, Zeck J, Jaskowiak N, Sattar H, Naik AM, Lee MC, Rosa M, Khazai L, Rendi MH, Lang JE, Lu J, Tawfik O, Asare SM, Esserman LJ, Mukhtar RA. PMID: 36069821; PMCID: PMC9453630.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Correction to: Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast. Mod Pathol. 2022 Oct; 35(10):1494-1495. Bean GR, Najjar S, Shin SJ, Hosfield EM, Caswell-Jin JL, Urisman A, Jones KD, Chen YY, Krings G. PMID: 35697932; PMCID: PMC9514987.
      View in: PubMed   Mentions:    Fields:    
    7. A 3D printed pulmonary mock loop for hemodynamic studies in congenital heart disease. Biomed Phys Eng Express. 2022 09 05; 8(6). Conijn M, Wintermans LM, Metselaar R, Ruisch J, Bax EA, van Egmond CAW, Nieuwenstein B, Warmerdam EG, Krings GJ. PMID: 35970091.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy. Arch Pathol Lab Med. 2022 Aug 17. Sahoo S, Krings G, Chen YY, Carter JM, Chen B, Guo H, Hibshoosh H, Reisenbichler E, Fan F, Wei S, Khazai L, Balassanian R, Klein ME, Shad S, Venters SJ, Borowsky AD, Symmans WF, Ocal IT. PMID: 35976643.
      View in: PubMed   Mentions:    Fields:    
    9. Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast. Mod Pathol. 2022 10; 35(10):1349-1361. Bean GR, Najjar S, Shin SJ, Hosfield EM, Caswell-Jin JL, Urisman A, Jones KD, Chen YY, Krings G. PMID: 35590107; PMCID: PMC9514991.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Treatment Efficacy Score-continuous residual cancer burden-based metric to compare neoadjuvant chemotherapy efficacy between randomized trial arms in breast cancer trials. Ann Oncol. 2022 08; 33(8):814-823. Marczyk M, Mrukwa A, Yau C, Wolf D, Chen YY, Balassanian R, Nanda R, Parker BA, Krings G, Sattar H, Zeck JC, Albain KS, Boughey JC, Liu MC, Elias AD, Clark AS, Venters SJ, Shad S, Basu A, Asare SM, Buxton M, Asare AL, Rugo HS, Perlmutter J, DeMichele AM, Yee D, Berry DA, Veer LV, Symmans WF, Esserman L, Pusztai L, I-SPY Consortium. PMID: 35513244.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    11. Assessment of Residual Cancer Burden and Event-Free Survival in Neoadjuvant Treatment for High-risk Breast Cancer: An Analysis of Data From the I-SPY2 Randomized Clinical Trial. JAMA Oncol. 2021 Nov 01; 7(11):1654-1663. Symmans WF, Yau C, Chen YY, Balassanian R, Klein ME, Pusztai L, Nanda R, Parker BA, Datnow B, Krings G, Wei S, Feldman MD, Duan X, Chen B, Sattar H, Khazai L, Zeck JC, Sams S, Mhawech-Fauceglia P, Rendi M, Sahoo S, Ocal IT, Fan F, LeBeau LG, Vinh T, Troxell ML, Chien AJ, Wallace AM, Forero-Torres A, Ellis E, Albain KS, Murthy RK, Boughey JC, Liu MC, Haley BB, Elias AD, Clark AS, Kemmer K, Isaacs C, Lang JE, Han HS, Edmiston K, Viscusi RK, Northfelt DW, Khan QJ, Leyland-Jones B, Venters SJ, Shad S, Matthews JB, Asare SM, Buxton M, Asare AL, Rugo HS, Schwab RB, Helsten T, Hylton NM, van 't Veer L, Perlmutter J, DeMichele AM, Yee D, Berry DA, Esserman LJ. PMID: 34529000; PMCID: PMC8446908.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    12. Modulation of the immune microenvironment of high-risk ductal carcinoma in situ by intralesional pembrolizumab injection. NPJ Breast Cancer. 2021 May 25; 7(1):59. Glencer AC, Wong JM, Hylton NM, Krings G, McCune E, Rothschild HT, Loveday TA, Alvarado MD, Esserman LJ, Campbell MJ. PMID: 34035311; PMCID: PMC8149838.
      View in: PubMed   Mentions: 1  
    13. Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer before chemo-endocrine therapy. Ann Oncol. 2021 05; 32(5):642-651. Du L, Yau C, Brown-Swigart L, Gould R, Krings G, Hirst GL, Bedrosian I, Layman RM, Carter JM, Klein M, Venters S, Shad S, van der Noordaa M, Chien AJ, Haddad T, Isaacs C, Pusztai L, Albain K, Nanda R, Tripathy D, Liu MC, Boughey J, Schwab R, Hylton N, DeMichele A, Perlmutter J, Yee D, Berry D, Van't Veer L, Valero V, Esserman LJ, Symmans WF. PMID: 33617937.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    14. Abstract PS4-09: Pathologic features of the inter-regimen biopsy predict response to neoadjuvant therapy in the I-SPY 2 TRIAL. Cancer Research. 2021 Feb 15; 81(4_Supplement):ps4-09-ps4-09. Carter CJ, Klein KM, Venters VS, Rabe RK, Ocal OI, Singh SK, Wolf WD, Sahoo SS, Harada HS, Khazai KL, Harigopal HM, Borowsky BA, Krings KG, Balassanian BR, Chen CY, Cole CK, Shad SS, Delson DA, Brown-Swigart BL, Esserman EL, van ‘t Veer vL, Symmans SW. .
      View in: Publisher Site   Mentions:
    15. Abstract PS1-03: Active surveillance for DCIS: Clinical outcomes at 5.6 years mean follow-up. Cancer Research. 2021 Feb 15; 81(4_Supplement):ps1-03-ps1-03. Brabham BC, Mukhtar MR, Liang LA, Kim KP, Hirst HG, Basu BA, Greenwood GH, Freimanis FR, Borowsky BA, Hwang HS, Baehner BR, Krings KG, Hylton HN, Esserman EL. .
      View in: Publisher Site   Mentions:
    16. Inflammation Mediates the Development of Aggressive Breast Cancer Following Radiotherapy. Clin Cancer Res. 2021 03 15; 27(6):1778-1791. Ma L, Gonzalez-Junca A, Zheng Y, Ouyang H, Illa-Bochaca I, Horst KC, Krings G, Wang Y, Fernandez-Garcia I, Chou W, Barcellos-Hoff MH. PMID: 33402361; PMCID: PMC7956216.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    17. Low-grade endometrial stromal sarcoma metastatic to the breast: Immunohistochemical and molecular characterization of an unusual mimic of mammary myofibroblastoma. Human Pathology Case Reports. 2020 Nov 1; 22:200447. Elliott ED, Pekmezci PM, Geiersbach GK, Krings KG, Rabban RJ, Zaloudek ZC, Chen CY. .
      View in: Publisher Site   Mentions:
    18. Association of Event-Free and Distant Recurrence-Free Survival With Individual-Level Pathologic Complete Response in Neoadjuvant Treatment of Stages 2 and 3 Breast Cancer: Three-Year Follow-up Analysis for the I-SPY2 Adaptively Randomized Clinical Trial. JAMA Oncol. 2020 09 01; 6(9):1355-1362. I-SPY2 Trial Consortium, Yee D, DeMichele AM, Yau C, Isaacs C, Symmans WF, Albain KS, Chen YY, Krings G, Wei S, Harada S, Datnow B, Fadare O, Klein M, Pambuccian S, Chen B, Adamson K, Sams S, Mhawech-Fauceglia P, Magliocco A, Feldman M, Rendi M, Sattar H, Zeck J, Ocal IT, Tawfik O, LeBeau LG, Sahoo S, Vinh T, Chien AJ, Forero-Torres A, Stringer-Reasor E, Wallace AM, Pusztai L, Boughey JC, Ellis ED, Elias AD, Lu J, Lang JE, Han HS, Clark AS, Nanda R, Northfelt DW, Khan QJ, Viscusi RK, Euhus DM, Edmiston KK, Chui SY, Kemmer K, Park JW, Liu MC, Olopade O, Leyland-Jones B, Tripathy D, Moulder SL, Rugo HS, Schwab R, Lo S, Helsten T, Beckwith H, Haugen P, Hylton NM, Van't Veer LJ, Perlmutter J, Melisko ME, Wilson A, Peterson G, Asare AL, Buxton MB, Paoloni M, Clennell JL, Hirst GL, Singhrao R, Steeg K, Matthews JB, Asare SM, Sanil A, Berry SM, Esserman LJ, Berry DA. PMID: 32701140; PMCID: PMC7378873.
      View in: PubMed   Mentions: 40     Fields:    Translation:Humans
    19. A risk-associated Active transcriptome phenotype expressed by histologically normal human breast tissue and linked to a pro-tumorigenic adipocyte population. Breast Cancer Res. 2020 07 31; 22(1):81. Kang T, Yau C, Wong CK, Sanborn JZ, Newton Y, Vaske C, Benz SC, Krings G, Camarda R, Henry JE, Stuart J, Powell M, Benz CC. PMID: 32736587; PMCID: PMC7395362.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    20. A phase Ib trial of the cyclin-dependent kinase inhibitor dinaciclib (dina) in combination with pembrolizumab (P) in patients with advanced triple-negative breast cancer (TNBC) and response correlation with MYC-overexpression. Journal of Clinical Oncology. 2020 May 20; 38(15_suppl):1076-1076. Chien CA, Gliwa GA, Rahmaputri RS, Dittrich DH, Majure MM, Rugo RH, Melisko MM, Munster MP, Park PJ, Moasser MM, Matloubian MM, Lea LT, Rohrberg RJ, Krings KG, Goga GA. .
      View in: Publisher Site   Mentions:
    21. Evaluation of ductal carcinoma in situ grade via triple-modal molecular imaging of B7-H3 expression. NPJ Breast Cancer. 2020; 6:14. Bachawal S, Bean GR, Krings G, Wilson KE. PMID: 32377564; PMCID: PMC7190737.
      View in: PubMed   Mentions: 4  
    22. Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival. Breast Cancer Res Treat. 2020 May; 181(1):23-29. Mukhtar RA, Krings G, Chen YY, Mamounas ME, Fahrner-Scott K, Wong J, Alvarado M, Ewing C, Esserman LJ, Rugo H. PMID: 32240457.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Phase II Single-Arm Study of Preoperative Letrozole for Estrogen Receptor-Positive Postmenopausal Ductal Carcinoma In Situ: CALGB 40903 (Alliance). J Clin Oncol. 2020 04 20; 38(12):1284-1292. Hwang ES, Hyslop T, Hendrix LH, Duong S, Bedrosian I, Price E, Caudle A, Hieken T, Guenther J, Hudis CA, Winer E, Lyss AP, Dickson-Witmer D, Hoefer R, Ollila DW, Hardman T, Marks J, Chen YY, Krings G, Esserman L, Hylton N. PMID: 32125937; PMCID: PMC7164489.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    24. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis. Mod Pathol. 2020 08; 33(8):1518-1526. Beca F, Krings G, Chen YY, Hosfield EM, Vohra P, Sibley RK, Troxell ML, West RB, Allison KH, Bean GR. PMID: 32123305.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    25. Abstract P6-10-02: Assessing biomarkers to inform treatment de-escalation: Mid-treatment biopsy cellularity predicts pCR in the I-SPY 2 Trial. Cancer Research. 2020 Feb 15; 80(4_Supplement):p6-10-02-p6-10-02. Venters VS, Wolf WD, Brown-Swigart BL, Yau YC, Delson DA, Parker PB, Balassanian BR, Carter CJ, Chen CY, Cole CK, Khazai KL, Klein KM, Kokh KD, Krings KG, Sahoo SS, Wei WJ, Esserman EL, van't Veer vL, Symmans SW. .
      View in: Publisher Site   Mentions:
    26. Abstract P3-08-20: The normal breast Active transcriptome associated with future breast cancer risk is driven by a dysregulated adipocyte microenvironment. Cancer Research. 2020 Feb 15; 80(4_Supplement):p3-08-20-p3-08-20. Benz BC, Kang KT, Yau YC, Wong WC, Newton NY, Vaske VC, Benz BS, Krings KG, Camarda CR, Henry HJ, Stuart SJ, Powell PM. .
      View in: Publisher Site   Mentions:
    27. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma. Mod Pathol. 2020 06; 33(6):1078-1091. Shamir ER, Chen YY, Krings G. PMID: 31907376.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    28. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity. Mod Pathol. 2020 06; 33(6):1056-1064. Pareja F, da Silva EM, Frosina D, Geyer FC, Lozada JR, Basili T, Da Cruz Paula A, Zhong E, Derakhshan F, D'Alfonso T, Wen HY, Giri DD, Hayes MM, Krings G, Bhargava R, Palazzo JP, Rakha EA, Hoda SA, Sanders ME, Collins LC, Schnitt SJ, Chen YY, Weigelt B, Jungbluth AA, Reis-Filho JS, Brogi E. PMID: 31896809; PMCID: PMC7286791.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    29. Pan-TRK Immunohistochemistry: A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast. Am J Surg Pathol. 2019 12; 43(12):1693-1700. Harrison BT, Fowler E, Krings G, Chen YY, Bean GR, Vincent-Salomon A, Fuhrmann L, Barnick SE, Chen B, Hosfield EM, Hornick JL, Schnitt SJ. PMID: 31498178.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    30. Genomic profiling of combined hepatocellular-cholangiocarcinoma reveals similar genetics to hepatocellular carcinoma. J Pathol. 2019 06; 248(2):164-178. Joseph NM, Tsokos CG, Umetsu SE, Shain AH, Kelley RK, Onodera C, Bowman S, Talevich E, Ferrell LD, Kakar S, Krings G. PMID: 30690729.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    31. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center. Am J Surg Pathol. 2019 03; 43(3):399-408. Shamir ER, Chen YY, Chu T, Pekmezci M, Rabban JT, Krings G. PMID: 30489319.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    32. CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast. Histopathology. 2019 Feb; 74(3):463-473. Bean GR, Krings G, Otis CN, Solomon DA, García JJ, van Zante A, Camelo-Piragua S, van Ziffle J, Chen YY. PMID: 30380176.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer. Nat Med. 2019 01; 25(1):111-118. Shah KN, Bhatt R, Rotow J, Rohrberg J, Olivas V, Wang VE, Hemmati G, Martins MM, Maynard A, Kuhn J, Galeas J, Donnella HJ, Kaushik S, Ku A, Dumont S, Krings G, Haringsma HJ, Robillard L, Simmons AD, Harding TC, McCormick F, Goga A, Blakely CM, Bivona TG, Bandyopadhyay S. PMID: 30478424; PMCID: PMC6324945.
      View in: PubMed   Mentions: 108     Fields:    Translation:HumansAnimalsCells
    34. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation. Mod Pathol. 2019 02; 32(2):280-289. Bean GR, Anderson J, Sangoi AR, Krings G, Garg K. PMID: 30266945.
      View in: PubMed   Mentions: 16     Fields:    Translation:Humans
    35. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma. Mod Pathol. 2019 02; 32(2):290-305. Shamir ER, Devine WP, Pekmezci M, Umetsu SE, Krings G, Federman S, Cho SJ, Saunders TA, Jen KY, Bergsland E, Jones K, Kim GE, Kakar S, Chiu CY, Joseph NM. PMID: 30237525.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    36. Intratumor Heterogeneity of the Estrogen Receptor and the Long-term Risk of Fatal Breast Cancer. J Natl Cancer Inst. 2018 07 01; 110(7):726-733. Lindström LS, Yau C, Czene K, Thompson CK, Hoadley KA, Van't Veer LJ, Balassanian R, Bishop JW, Carpenter PM, Chen YY, Datnow B, Hasteh F, Krings G, Lin F, Zhang Y, Nordenskjöld B, Stål O, Benz CC, Fornander T, Borowsky AD, Esserman LJ, STO Trialists Group. PMID: 29361175; PMCID: PMC6037086.
      View in: PubMed   Mentions: 33     Fields:    Translation:Humans
    37. Genomic profiling of metaplastic breast carcinomas reveals genetic heterogeneity and relationship to ductal carcinoma. Mod Pathol. 2018 11; 31(11):1661-1674. Krings G, Chen YY. PMID: 29946183.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    38. EWSR1-NFATC2 gene fusion in a soft tissue tumor with epithelioid round cell morphology and abundant stroma: a case report and review of the literature. Hum Pathol. 2018 11; 81:281-290. Cohen JN, Sabnis AJ, Krings G, Cho SJ, Horvai AE, Davis JL. PMID: 29626598; PMCID: PMC8104452.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    39. 452 (PB-085) The impact of mitotic score versus pleomorphic subtype on disease free survival in invasive lobular carcinoma of the breast. European Journal of Cancer. 2018 Apr 1; 92:s132. Mamounas MM, Wong WJ, Fahrner-Scott FK, Chen CY, Krings KG, Ewing EC, Esserman EL, Alvarado AM, Rugo RH, Mukhtar MR. .
      View in: Publisher Site   Mentions:
    40. Local delivery of hormonal therapy with silastic tubing for prevention and treatment of breast cancer. Sci Rep. 2018 01 08; 8(1):92. Park J, Thomas S, Zhong AY, Wolfe AR, Krings G, Terranova-Barberio M, Pawlowska N, Benet LZ, Munster PN. PMID: 29311658; PMCID: PMC5758798.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    41. HDAC inhibition potentiates immunotherapy in triple negative breast cancer. Oncotarget. 2017 Dec 26; 8(69):114156-114172. Terranova-Barberio M, Thomas S, Ali N, Pawlowska N, Park J, Krings G, Rosenblum MD, Budillon A, Munster PN. PMID: 29371976; PMCID: PMC5768393.
      View in: PubMed   Mentions: 76     Fields:    
    42. Comprehensive analysis of normal adjacent to tumor transcriptomes. Nat Commun. 2017 10 20; 8(1):1077. Aran D, Camarda R, Odegaard J, Paik H, Oskotsky B, Krings G, Goga A, Sirota M, Butte AJ. PMID: 29057876; PMCID: PMC5651823.
      View in: PubMed   Mentions: 210     Fields:    Translation:HumansCells
    43. Heterogeneous drug penetrance of veliparib and carboplatin measured in triple negative breast tumors. Breast Cancer Res. 2017 Sep 11; 19(1):107. Bartelink IH, Prideaux B, Krings G, Wilmes L, Lee PRE, Bo P, Hann B, Coppé JP, Heditsian D, Swigart-Brown L, Jones EF, Magnitsky S, Keizer RJ, de Vries N, Rosing H, Pawlowska N, Thomas S, Dhawan M, Aggarwal R, Munster PN, Esserman LJ, Ruan W, Wu AHB, Yee D, Dartois V, Savic RM, Wolf DM, van 't Veer L. PMID: 28893315; PMCID: PMC5594551.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    44. Myofibroblastic, fibroblastic and myoid lesions of the breast. Semin Diagn Pathol. 2017 Sep; 34(5):427-437. Krings G, McIntire P, Shin SJ. PMID: 28751104.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    45. Fibroepithelial lesions; The WHO spectrum. Semin Diagn Pathol. 2017 Sep; 34(5):438-452. Krings G, Bean GR, Chen YY. PMID: 28688536.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    46. Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas. Mod Pathol. 2017 08; 30(8):1086-1099. Krings G, Joseph NM, Bean GR, Solomon D, Onodera C, Talevich E, Yeh I, Grenert JP, Hosfield E, Crawford ED, Jordan RC, van Zante A, Zaloudek C, Shin SJ, Chen YY. PMID: 28548128.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    47. Targeted next-generation DNA sequencing of paired tumor and normal DNA to reveal frequent actionable germline alterations. Journal of Clinical Oncology. 2017 May 20; 35(15_suppl):11575-11575. Korn KW, Yey YI, Van Ziffle VJ, Grenert GJ, Joseph JN, Solomon SD, Laurance LM, Talevich TE, Onodera OC, Krings KG, Stohr SB, Blanco BA, Bastian BB. .
      View in: Publisher Site   Mentions:
    48. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017 Feb; 241(3):375-391. Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH. PMID: 27861902; PMCID: PMC5499709.
      View in: PubMed   Mentions: 46     Fields:    Translation:Humans
    49. Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2017 01; 161(1):17-28. Campbell MJ, Baehner F, O'Meara T, Ojukwu E, Han B, Mukhtar R, Tandon V, Endicott M, Zhu Z, Wong J, Krings G, Au A, Gray JW, Esserman L. PMID: 27785654; PMCID: PMC5225037.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    50. 'Non-classical' HER2 FISH results in breast cancer: a multi-institutional study. Mod Pathol. 2017 02; 30(2):227-235. Ballard M, Jalikis F, Krings G, Schmidt RA, Chen YY, Rendi MH, Dintzis SM, Jensen KC, West RB, Sibley RK, Troxell ML, Allison KH. PMID: 27739440.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    51. Proliferative index facilitates distinction between benign biliary lesions and intrahepatic cholangiocarcinoma. Hum Pathol. 2016 11; 57:61-67. Tsokos CG, Krings G, Yilmaz F, Ferrell LD, Gill RM. PMID: 27396933; PMCID: PMC5250508.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    52. Small-cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population. Histopathology. 2016 Oct; 69(4):667-79. McKelvie PA, Climent F, Krings G, Hasserjian RP, Abramson JS, Pilch BZ, Harris NL, Ferry JA, Zukerberg LR, Sohani AR. PMID: 27144366.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    53. Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol. 2016 09; 29(9):1012-27. Liu SY, Joseph NM, Ravindranathan A, Stohr BA, Greenland NY, Vohra P, Hosfield E, Yeh I, Talevich E, Onodera C, Van Ziffle JA, Grenert JP, Bastian BC, Chen YY, Krings G. PMID: 27255162.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCells
    54. SOX2 O-GlcNAcylation alters its protein-protein interactions and genomic occupancy to modulate gene expression in pluripotent cells. Elife. 2016 Mar 07; 5:e10647. Myers SA, Peddada S, Chatterjee N, Friedrich T, Tomoda K, Krings G, Thomas S, Maynard J, Broeker M, Thomson M, Pollard K, Yamanaka S, Burlingame AL, Panning B. PMID: 26949256; PMCID: PMC4841768.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    55. Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med. 2016 04; 22(4):427-32. Camarda R, Zhou AY, Kohnz RA, Balakrishnan S, Mahieu C, Anderton B, Eyob H, Kajimura S, Tward A, Krings G, Nomura DK, Goga A. PMID: 26950360; PMCID: PMC4892846.
      View in: PubMed   Mentions: 225     Fields:    Translation:HumansCells
    56. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type. Am J Surg Pathol. 2016 Mar; 40(3):419-32. Moh M, Krings G, Ates D, Aysal A, Kim GE, Rabban JT. PMID: 26551622.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    57. Less Common Triple Negative Breast Cancers. A Comprehensive Guide to Core Needle Biopsies of the Breast. 2016 Jan 1; 445-518. Vohra VP, Krings KG, Chen CY. .
      View in: Publisher Site   Mentions:
    58. Fibroepithelial Lesions. A Comprehensive Guide to Core Needle Biopsies of the Breast. 2016 Jan 1; 241-319. Krings KG, Chen CY. .
      View in: Publisher Site   Mentions:
    59. Spatial distribution of veliparib measured by matrix-assisted laser desorption ionization mass spectrometry in triple-negative breast cancer tumors. Journal of Clinical Oncology. 2014 Sep 10; 32(26_suppl):161-161. Bartelink BI, Prideaux PB, Hann HB, Krings KG, Coppe CJ, Brown Swigart BL, Lee LE, Esserman EL, Yee YD, Wolf WD, Savic SR. .
      View in: Publisher Site   Mentions:
    60. Diagnostic utility and sensitivities of GATA3 antibodies in triple-negative breast cancer. Hum Pathol. 2014 Nov; 45(11):2225-32. Krings G, Nystrom M, Mehdi I, Vohra P, Chen YY. PMID: 25150746.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    61. Predictive biomarkers of invasive carcinoma on excision in patients with a diagnosis of ductal carcinoma in situ of the breast by needle biopsy. Journal of Clinical Oncology. 2014 May 20; 32(15_suppl):e12029-e12029. Mori MM, Krings KG, Chan CL, Wolf WD, Chen CY, Kerlikowske KK, Tlsty TT, Coppe CJ, Matsuda MN, Suzuki SK, Nakamura NS, van't Veer vL. .
      View in: Publisher Site   Mentions:
    62. Aberrant centrizonal features in chronic hepatic venous outflow obstruction: centrilobular mimicry of portal-based disease. Am J Surg Pathol. 2014 Feb; 38(2):205-14. Krings G, Can B, Ferrell L. PMID: 24418854.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    63. Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma. Mod Pathol. 2013 Jun; 26(6):782-91. Krings G, Ramachandran R, Jain D, Wu TT, Yeh MM, Torbenson M, Kakar S. PMID: 23348905.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    64. Ocular melanoma metastatic to the pancreas after a 28-year disease-free interval. Surgery. 2010 Jul; 148(1):151-4. Vagefi PA, Stangenberg L, Krings G, Forcione DG, Wargo JA. PMID: 19744448.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    65. Replication termination mechanism as revealed by Tus-mediated polar arrest of a sliding helicase. Proc Natl Acad Sci U S A. 2008 Sep 02; 105(35):12831-6. Bastia D, Zzaman S, Krings G, Saxena M, Peng X, Greenberg MM. PMID: 18708526; PMCID: PMC2529109.
      View in: PubMed   Mentions: 23     Fields:    Translation:Cells
    66. Molecular architecture of a eukaryotic DNA replication terminus-terminator protein complex. Mol Cell Biol. 2006 Nov; 26(21):8061-74. Krings G, Bastia D. PMID: 16940176; PMCID: PMC1636744.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    67. Sap1p binds to Ter1 at the ribosomal DNA of Schizosaccharomyces pombe and causes polar replication fork arrest. J Biol Chem. 2005 Nov 25; 280(47):39135-42. Krings G, Bastia D. PMID: 16195226.
      View in: PubMed   Mentions: 42     Fields:    Translation:AnimalsCells
    68. swi1- and swi3-dependent and independent replication fork arrest at the ribosomal DNA of Schizosaccharomyces pombe. Proc Natl Acad Sci U S A. 2004 Sep 28; 101(39):14085-90. Krings G, Bastia D. PMID: 15371597; PMCID: PMC521093.
      View in: PubMed   Mentions: 70     Fields:    Translation:AnimalsCells
    69. Chlamydophila pneumoniae induces ICAM-1 expression in human aortic endothelial cells via protein kinase C-dependent activation of nuclear factor-kappaB. Circ Res. 2003 May 30; 92(10):1130-7. Vielma SA, Krings G, Lopes-Virella MF. PMID: 12714566.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    70. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Clin Immunol. 2000 May; 95(2):135-44. Virella G, Koskinen S, Krings G, Onorato JM, Thorpe SR, Lopes-Virella M. PMID: 10779407.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansCells
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Gregor's Networks
    Concepts (312)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (97)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.